Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients (EVOLVE)

Clinical Trial ID NCT02028442

PubWeight™ 5.96^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02028442

Top papers